Skip to main content
Premium Trial:

Request an Annual Quote

BioCat to Distribute SwitchGear System in Europe

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SwitchGear Genomics today said that Heidelberg, Germany-based BioCat will distribute the firm's LightSwitch Luciferase Assay System in Europe.

Specifically, the deal covers Germany, Austria, and Switzerland, with full sales, marketing, and technical support from Menlo Park, Calif.-based SwitchGear. Further terms of the agreement were not disclosed.

The LightSwitch system includes a genome-wide collection of human promoter and 3' UTR luciferase reporters and translational efficiency in living cells.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.